Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Acceptability of a Bioadhesive Nonoxynol-9 Gel Delivered by an Applicator as a Rectal Microbicide

Article Abstract:

Nonoxynol-9 gel may not be acceptable to many gay men in its current form. This gel was developed to prevent HIV infection. It can be inserted into the vagina or rectum so it could be used by women and gay men. Researchers tested a nonoxynol-9 gel called Advantage 24 in 25 HIV-negative and 10 HIV-positive gay men and their partners. Only 58% of the men who wanted some type of HIV preventive method said they would use the gel. Many complained of side effects, discomfort from the applicator, and said the gel was too sticky.

Author: TABET, STEPHEN R., COLETTI, ANNE S., GROSS, MICHAEL, KELLY, CLIFTON W., CELUM, CONNIE L., CHESNEY, MARGARET A.
Publisher: American Venereal Disease Association
Publication Name: Sexually Transmitted Diseases
Subject: Health
ISSN: 0148-5717
Year: 1999
Nonoxynol 9, Gels (Pharmacy)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Intoxications, intentions, and disease preventions

Article Abstract:

People who exhibit a cycle of dysfunctional living, drug usage, and unsafe sex habits may be the appropriate targets for comprehensive HIV prevention campaigns that include safe sex and substance abuse prevention components. Contrary to popular belief, recreational drug users typically find a way to balance their drug use with safe sex habits. Recent research has shown that drug use among teenage women does not seem to affect condom use patterns, particularly among those who already routinely use condoms.

Author: Des Jarlais, Don C.
Publisher: American Venereal Disease Association
Publication Name: Sexually Transmitted Diseases
Subject: Health
ISSN: 0148-5717
Year: 1997
Editorial, Services, Study and teaching, Drug addicts, Drug abusers, Safe sex

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Acceptability of Formulations and Application Methods for Vaginal Microbicides Among Drug-Involved Women

Article Abstract:

Different women may prefer different female-controlled methods of HIV prevention. These methods include medicated gels that are inserted in the vagina and the female condom. Eighty-four female drug users were asked to try three different products for three weeks. Most of the women liked the products and said they would use them if the product was effective against HIV. Race, cultural background, age, and the male partner can influence women's use of these methods.

Author: HAMMETT, THEODORE M., MASON, THERESA H., JOANIS, CAROL L., FOSTER, SUSAN E., HARMON, PATRICIA, ROBLES, RAFAELA R., FINLINSON, H. ANN, FEUDO, RUDY, VINING-BETHEA, SANDRA, JETER, GARRY, MAYER, KENNETH H., DOHERTY-IDDINGS, PAULA, SEAGE, GEORGE R. III
Publisher: American Venereal Disease Association
Publication Name: Sexually Transmitted Diseases
Subject: Health
ISSN: 0148-5717
Year: 2000
Women, HIV infection in women, Vagina, Medication by, Vaginal medication

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Evaluation, Prevention, HIV infection, HIV infections
Similar abstracts:
  • Abstracts: Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behcet's disease. Interaction between synoviocytes and extracellular matrix in vivo
  • Abstracts: A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine
  • Abstracts: Analysis of labor and delivery workload. A "bottom-line" approach to nurse staffing. Census variation staffing
  • Abstracts: Nutritional status of HIV-1 seropositive patients in the Free State province of South Africa: anthropometric and dietary profile
  • Abstracts: Breast cancer susceptibility genes: current challenges and future promises. Researchers puzzle over origin of type 2 diabetes
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.